4-Methylphenylhydrazine monohydrochloride → ethyl 8-methyl-1,3,4,5-tetrahydro-2H-pyrido[4,3-b]indole-2-carboxylate

HRID 332086

反応式

HRID 332086 の反応式
Cl.[C:2]1([CH3:10])[CH:7]=[CH:6][C:5]([NH:8]N)=[CH:4][CH:3]=1.[C:11]([N:16]1[CH2:21][CH2:20][C:19](=O)[CH2:18][CH2:17]1)([O:13][CH2:14][CH3:15])=[O:12]>CCO>[CH3:10][C:2]1[CH:7]=[CH:6][C:5]2[NH:8][C:19]3[CH2:20][CH2:21][N:16]([C:11]([O:13][CH2:14][CH3:15])=[O:12])[CH2:17][C:18]=3[C:4]=2[CH:3]=1

参加物

4

実験手順

Following a literature procedure (Harbert et al., J. Med. Chem. 1980, 23, 635-643) p-tolylhydrazine hydrochloride (0.500 g, 3.15 mmol) and 1-carbethoxy-4-piperidone (0.18 mL, 1.17 mmol) were suspended in EtOH (0.880 mL) and heated to reflux for 2 hours. The reaction mixture was removed from heat and allowed to stand overnight at ambient temperature. The resulting mixture was filtered and washed with 50% aqueous EtOH to afford the desired product as a beige powder (259 mg, 86%).

後処理

  1. temperatureheated
  2. temperatureto reflux for 2 hours
  3. customThe reaction mixture was removed
  4. temperaturefrom heat
  5. filtrationThe resulting mixture was filtered
  6. washwashed with 50% aqueous EtOH

出典と根拠

ORDレコード
ord-ef040a609efa4f619075f75ce7b569ec
出典データセット
uspto-grants-2014_11
特許番号
US08877797B2

関連ノート

読み込み中…